Skip Nav | Home | Mobile | Editorial Guidelines | Mission Statement | About Us | Contact | Help | Security | Support Us

World

Alimta approved by NICE for asbestos cancer mesothelioma

Forum of Asbestos Victim Support Groups UK | 08.07.2007 23:34 | Analysis | Health | Workers' Movements | World

The Forum of Asbestos Victim Support Groups welcomes the National Institute for Health and Clinical Excellence (NICE) Final Appraisal Determination which has today approved the use of Alimta to treat the terminal asbestos cancer, mesothelioma.

Today’s news appears a change of heart by NICE which now recommends the use Alimta, the only licensed drug for the treatment of mesothelioma, within the NHS. This decision ends over two years of post code lottery provision during which time mesothelioma patients in Scotland, Greater Manchester and the North East received treatment denied to patients elsewhere in the UK.

This decision acknowledges the poor prognosis of mesothelioma sufferers and the importance of providing treatment which, although not curative, can be efficacious for some patients suffering from very aggressive and rare cancers. NICE also acknowledges that mesothelioma is uniquely caused by exposure to asbestos

James Hilditch, who suffers from mesothelioma and has received treatment with Alimta says:

“I would not be here today if I had not been treated with Alimta. At last every mesothelioma sufferer can be assessed for treatment, which can be of great help to some mesothelioma patients. This is a good decision by NICE which will be welcomed by mesothelioma sufferers, their families and their doctors throughout the UK.”

Tony Whitston, Chair of the Forum of Asbestos Victims Support Groups UK, says:

“This excellent decision by NICE must now be swiftly acted on by PCTs throughout the country… Department of Health Guidance advises that every PCT “ should use its best endeavours to ensure that any new treatments recommended by NICE are available as soon as possible after NICE issues Technology Appraisal Guidance.”

“We are calling on all PCTs to fully comply with this guidance and to make immediate arrangements for the provision of Alimta for the treatment of mesothelioma”.

“We would like to thank all those who have campaigned for this treatment for mesothelioma, a disease caused almost exclusively by asbestos exposure and which was, and is, entirely preventable”.



For more information contact Tony Whitston or Hazel Bowden, Greater Manchester Asbestos Victims Support Group, Tel: 0161 636 7555.

N.I.C.E. Final Appraisal Determination can be viewed at:  http://guidance.nice.org.uk/page.aspx?o=439351

Forum of Asbestos Victim Support Groups UK
- Homepage: http://www.ActionMeso.info

Publish

Publish your news

Do you need help with publishing?

/regional publish include --> /regional search include -->

World Topics

Afghanistan
Analysis
Animal Liberation
Anti-Nuclear
Anti-militarism
Anti-racism
Bio-technology
Climate Chaos
Culture
Ecology
Education
Energy Crisis
Fracking
Free Spaces
Gender
Globalisation
Health
History
Indymedia
Iraq
Migration
Ocean Defence
Other Press
Palestine
Policing
Public sector cuts
Repression
Social Struggles
Technology
Terror War
Workers' Movements
Zapatista

Kollektives

Birmingham
Cambridge
Liverpool
London
Oxford
Sheffield
South Coast
Wales
World

Other UK IMCs
Bristol/South West
London
Northern Indymedia
Scotland

Server Appeal Radio Page Video Page Indymedia Cinema Offline Newsheet

secure Encrypted Page

You are viewing this page using an encrypted connection. If you bookmark this page or send its address in an email you might want to use the un-encrypted address of this page.

If you recieved a warning about an untrusted root certificate please install the CAcert root certificate, for more information see the security page.

IMCs


www.indymedia.org

Projects
print
radio
satellite tv
video

Africa

Europe
antwerpen
armenia
athens
austria
barcelona
belarus
belgium
belgrade
brussels
bulgaria
calabria
croatia
cyprus
emilia-romagna
estrecho / madiaq
galiza
germany
grenoble
hungary
ireland
istanbul
italy
la plana
liege
liguria
lille
linksunten
lombardia
madrid
malta
marseille
nantes
napoli
netherlands
northern england
nottingham imc
paris/île-de-france
patras
piemonte
poland
portugal
roma
romania
russia
sardegna
scotland
sverige
switzerland
torun
toscana
ukraine
united kingdom
valencia

Latin America
argentina
bolivia
chiapas
chile
chile sur
cmi brasil
cmi sucre
colombia
ecuador
mexico
peru
puerto rico
qollasuyu
rosario
santiago
tijuana
uruguay
valparaiso
venezuela

Oceania
aotearoa
brisbane
burma
darwin
jakarta
manila
melbourne
perth
qc
sydney

South Asia
india


United States
arizona
arkansas
asheville
atlanta
Austin
binghamton
boston
buffalo
chicago
cleveland
colorado
columbus
dc
hawaii
houston
hudson mohawk
kansas city
la
madison
maine
miami
michigan
milwaukee
minneapolis/st. paul
new hampshire
new jersey
new mexico
new orleans
north carolina
north texas
nyc
oklahoma
philadelphia
pittsburgh
portland
richmond
rochester
rogue valley
saint louis
san diego
san francisco
san francisco bay area
santa barbara
santa cruz, ca
sarasota
seattle
tampa bay
united states
urbana-champaign
vermont
western mass
worcester

West Asia
Armenia
Beirut
Israel
Palestine

Topics
biotech

Process
fbi/legal updates
mailing lists
process & imc docs
tech